Unseen costs of prior authorization

Prior authorizations are often used as a cost containment tactic by payers — and it works in reducing the amount that the payer must pay for the PA drug (i.e. in financial terms, the line item goes down). However, decreases in the line item are showing up somewhere else. At a study conducted at the … Continue reading